HHLR ADVISORS, LTD. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$350,739,000
+0.3%
2,962,0760.0%3.47%
+24.6%
Q4 2020$349,851,000
+6.3%
2,962,0760.0%2.78%
+11.5%
Q3 2020$329,205,000
+8.8%
2,962,0760.0%2.49%
-9.9%
Q2 2020$302,665,000
+1.9%
2,962,076
+7.7%
2.77%
-30.9%
Q1 2020$296,937,000
-7.3%
2,751,2000.0%4.00%
+0.3%
Q4 2019$320,185,000
+1.7%
2,751,2000.0%3.99%
-7.9%
Q3 2019$314,930,000
+20.1%
2,751,2000.0%4.33%
-26.2%
Q2 2019$262,189,000
+4.4%
2,751,2000.0%5.86%
-16.2%
Q1 2019$251,047,000
+20.2%
2,751,2000.0%6.99%
-19.3%
Q4 2018$208,844,0002,751,2008.66%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders